Labbé Annie-Claude, Poirier Louise, Maccannell Duncan, Louie Thomas, Savoie Michel, Béliveau Claire, Laverdière Michel, Pépin Jacques
Department of Microbiology, Hôpital Maisonneuve-Rosemont, Montréal, Québec, Canada.
Antimicrob Agents Chemother. 2008 Sep;52(9):3180-7. doi: 10.1128/AAC.00146-08. Epub 2008 Jun 23.
Since 2002, an epidemic of Clostridium difficile infections has occurred in southern Quebec, Canada. At Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada, the incidence of C. difficile infections increased from 11/1,000 admissions (1999 to 2002) to 27/1,000 admissions (2003 to 2005). We compared the exposures and outcomes for patients infected with strains with different ribopatterns isolated before (n = 55) and during (n = 175) the epidemic, as well as the in vitro activities of antibiotics against those isolates. During the preepidemic period, 46 isolates (84%) were of ribotype 001, 1 was of ribotype 027, and 8 were of other ribopattern types. During the epidemic period, ribotype 027 strains accounted for 140 (80%) isolates; 26 (15%) were of ribotype 001, and 7 were of other ribopattern types. Ribotype 027 strains were highly resistant to fluoroquinolones (FQs) but were susceptible to clindamycin. A pattern of prior specific antibiotic exposure that selected for antibiotic-resistant ribotype C. difficile infections was observed for FQs (ribotype 027) and clindamycin (ribotype 001). The rate of mortality was higher among older patients, those with a high Charlson comorbidity index, and those with longer previous hospitalizations. By multivariate analysis, patients infected with ribotype 027 were twice as likely to die within 30 days of diagnosis than patients infected with other ribotypes (adjusted odds ratio, 2.06; 95% confidence interval, 1.00 to 4.22). The observations from this study support the notion that continued selective antibiotic pressure resulted in the superimposition of the hypertoxigenic ribotype 027 clone on top of the prior dominant ribotype 001 clone in a setting of preexisting high endemicity, thus leading to the high rates of morbidity and mortality seen in the Quebec outbreak. Stringent antibiotic stewardship measures, combined with aggressive infection control, are required to curtail the epidemic of C. difficile infections.
自2002年以来,加拿大魁北克省南部发生了艰难梭菌感染疫情。在加拿大魁北克省蒙特利尔市的迈松纳夫-罗斯蒙特医院,艰难梭菌感染的发生率从1999年至2002年的每1000例入院患者中有11例,增至2003年至2005年的每1000例入院患者中有27例。我们比较了疫情之前(n = 55)和疫情期间(n = 175)分离出的具有不同核糖体分型的菌株感染患者的暴露情况和结局,以及抗生素对这些分离株的体外活性。在疫情前期,46株分离株(84%)为核糖体分型001,1株为核糖体分型027,8株为其他核糖体分型。在疫情期间,核糖体分型027菌株占140株(80%);26株(15%)为核糖体分型001,7株为其他核糖体分型。核糖体分型027菌株对氟喹诺酮类药物(FQs)高度耐药,但对克林霉素敏感。对于FQs(核糖体分型027)和克林霉素(核糖体分型001),观察到一种选择耐药性核糖体分型艰难梭菌感染的既往特定抗生素暴露模式。老年患者、查尔森合并症指数高的患者以及既往住院时间较长的患者死亡率较高。通过多变量分析,核糖体分型027感染的患者在诊断后30天内死亡的可能性是其他核糖体分型感染患者的两倍(调整后的优势比为2.06;95%置信区间为1.00至4.22)。这项研究的观察结果支持这样一种观点,即在先前高流行率的背景下,持续不断的选择性抗生素压力导致高毒力核糖体分型027克隆叠加在先前占主导地位的核糖体分型001克隆之上,从而导致魁北克疫情中出现高发病率和高死亡率。需要采取严格的抗生素管理措施,并结合积极的感染控制措施来遏制艰难梭菌感染疫情。